Genome-Wide Characterization of SARS-CoV-2 Cytopathogenic Proteins in the Search of Antiviral Targets
Abstract
The ongoing COVID-19 pandemic caused by SARS-CoV-2 has claimed over 5.5 million lives with more than 300 million people infected worldwide. While vaccines are effective, the emergence of new viral variants could jeopardize vaccine protection.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Feb 22, 2022
- Source ID
- 10.1128/mbio.00169-22
Entities
People
- J Marc Simard
- Jiantao Zhang
- Qi Li
- Qiyi Tang
- Richard Y. Zhao
- Ruth S. Cruz Cosme
- Volodymyr Gerzanich
Organizations
- Howard University
- National Heart, Lung, and Blood Institute
- National Institute of Allergy and Infectious Diseases
- National Institute of Neurological Disorders and Stroke
- United States Department of Defense
- United States Department of Veterans Affairs
- University of Maryland School of Medicine
- University of Maryland, Baltimore